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Zaheer-Ud-Din Babar1*, Shane Scahill1, Ayyaz Kiani2 and Caroline Vaughan3We are happy to announce the metamorphosis of the
Southern Med Review (SMR) into the Journal of Pharma-
ceutical Policy and Practice [1-3]. As an open access journal
published by BioMed Central [4-7], Journal of Pharmaceut-
ical Policy and Practice (JoPPP) will reach a greater number
of readers. Open access will lead to a wider readership,
higher downloads, higher citations, and a higher Impact
Factor [7-9]. Articles are archived in PubMed Central, and
other freely accessible full-text repositories which also ex-
tends the access by readership.
While rejoicing the start of an exciting new phase, it
seems appropriate to review where we have come from
and where are we heading with this new Journal. The first
issue (Vol 1 Issue 1) of SMR was published on 23rd Dec
2008 [1,2]. Since its beginning, nine issues have been pub-
lished which include a total of 70 articles. Issues covered
have included medicines access (governance, development
and pharmaceutical systems, pharmacoeconomics, medi-
cine pricing policies, patents and TRIPS, and affordability)
as well as medicines use (socio behavioural aspects of
medicine use, pharmacoepidemiology, pharmacovigilance,
drug utilization studies, pharmacy practice issues and
concerns) [1].
The main aim of SMR was to promote pharmaceutical
policy research from low and middle income countries - a
job which the journal did well. SMR provided opportunity
and support to emerging researchers with 30 to 40% of
the contributors being first time authors [1]. The journal
also published studies on the pharmaceutical situation
of countries where little or no pharmaceutical literature
is available e.g. Slovenia, Macedonia and Afghanistan
[10-12]. SMR was commended by the World Health Or-
ganisation (WHO) and its policy impact was evident
from published studies which were instrumental in* Correspondence: z.babar@auckland.ac.nz
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reproduction in any medium, provided the orchanges in the medicines pricing policies of Vietnam
and Thailand [13].
Now the journal is entering a new phase and is renamed
the Journal of Pharmaceutical Policy and Practice (JoPPP)
[3]. This change in title reflects a broadening in the remit
of the Journal. As alluded to above, each word in the title
of the new journal has been carefully selected and we have
taken the opportunity to outline what these words mean
to us and how we see them relating to the scope of JoPPP.
SMR was an internationally focussed journal with a
wide geographic and socioeconomic flavour; although
most of the research centred on the developing world
[1,2]. Academics residing in both the developed and the
developing world generated interesting policy and prac-
tice related work; more often policy than practice! We
expect that this will continue under the JoPPP flagship.
However, in line with the broadening remit we expect to
receive more pharmaceutical policy related work from
those in high-income countries.
The word Pharmaceutical was also chosen with care;
to be intentionally broad and to differentiate from Phar-
macy per se. The term pharmacy encompasses the phys-
ical structure of the community or hospital pharmacy
and the practices within that. However, pharmacies are
only one component of a larger complex health system
which influences global access to, and use of, medicines.
The term pharmaceutical encompasses pharmacy but is
broader in that it involves wider aspects of medicines ac-
cess and use including: technology, the pharmaceutical
industry, other health professionals that influence use
such as doctors and nurse prescribers and so forth.
Pharmaceutical policy includes such areas as national
pharmaceutical policy, pharmacoeconomics [14], regula-
tory affairs, pharmaceutical industry inspection; to name
just a few examples. There do however remain many un-
answered questions in the field of pharmaceutical policy.
From a practice viewpoint, international policy has
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[15]. However, there is little understanding of the degree
to which these policies are being adhered to and a global
systematic review of international medicines policies at
the level of the health system as a whole is yet to be
undertaken. These are considerable tasks and country
and/or continent level reviews of the status of pharma-
ceutical policy and practices would be useful. Defining
what “Pharmaceutical Policy” is globally, and its scope as a
concept and instrument for change across a range of
country contexts, will be a sensible first step to doing this.
Finally, adding the word ‘practice’ to the JoPPP title war-
rants consideration. There are a number of contexts that
encompass pharmaceutical practice and we will be par-
ticularly interested in the studies related to community
pharmacy setting. This could range from the papers
discussing policies and their impact on pharmaceutical
practice. Also, the interest would be in medicines compli-
ance, concordance, rationale use of medicines, medicines
use among minorities and the disadvantaged groups as
well those in the disaster or conflict zones.
We believe pharmaceutical policy is encompassing and
directing activities which are related to access to medi-
cines and their use. We look forward to receiving more
of these papers as JoPPP continues to grow and morph.
We encourage our readers to keep their contributions
rolling in!
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